Mycoplasma hyopneumoniae vaccine
US11141472B2 · kind B2 · utility
0Cited by
59References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2020 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Apr 27, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/10063
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a Mycoplasma hyopneumoniae (M. hyo) antigen that is compatible with antigens from other swine pathogens, wherein the M. hyo antigen is a cell free M. hyo culture supernatant which is substantially free of swine IgG.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.